Skip to main navigation
Krystal Biotech, Inc
  • Focus
    • Our Focus
    • Pipeline
    • Dystrophic EB
    • Netherton Syndrome
    • TGM1-deficient ARCI
    • Cystic Fibrosis
    • Aesthetic Skin Conditions
    • Chronic Skin Diseases
  • Patients and Families
    • Our Gene Therapy
    • Our Star-D Platform
    • Our Targets
    • Patient Advocacy
  • Medical Professional
  • About Us
  • Investors
    • Overview
    • News Releases
    • Events and Presentations
    • Corporate Governance
    • Analyst Coverage
    • Investor FAQs
    • SEC Filings
    • Stock Quote & Chart
    • Email Alerts
    • Select Scientific Publications
  • Contact
    • Careers
    • Contact Us
Contact Us

Investors

Investor Relations
  • Overview
  • News Releases
  • Events
  • Corporate Governance
  • Analyst Coverage
  • Investor FAQs
  • SEC Filings
  • Stock Quote
  • Email Alerts
  • Scientific Publications

SEC Filing Details

Document Details

Form
8-K/A
Filing Date
Aug 19, 2021
Document Date
Mar 24, 2021
Form Description
Amendment to a previously filed 8-K
Filing Group
Current Reports
Company
Krystal Biotech
Issuer
Krystal Biotech, Inc.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
XML - XBRL INSTANCE DOCUMENT

Quick Links

Focus
Patients and Families
Medical Professionals
About Us
Investors
Contact


© Krystal Biotech All Rights Reserved

Krystal Biotech, Inc.

2100 Wharton St. #701
Pittsburgh, PA 15203
412-586-5830
inquiries@krystalbio.com